Tens of millions of Americans have high cholesterol, which increases the risk of heart disease. Here & Now ‘s Peter O’Dowd ...

In June 2024, Resolution Therapeutics, in collaboration with the University of Edinburgh, presented pivotal RTX001 data at ...

AstraZeneca advances its ambition to redefine hematology care with new data from its diverse pipeline and portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, ...

Frederick, MD — Gov. Wes Moore on Friday announced that AstraZeneca will invest $2 billion to expand its operations in Maryland in what he described as the “single largest private investment in ...

DEVELOPMENTS FROM FREDERICK. THE INVESTMENT PROVIDES AN ECONOMIC SHOT IN THE ARM, CREATES JOBS AND BOOSTS THE STATE’S EFFORT TO EXPAND MARYLAND’S LIFE SCIENCES SECTOR. TODAY IS ABOUT SHOWING THAT WE ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its ...

We speak to pharmacist Oonagh O’Hagan on everything you need to know about diabetes, from the signs and symptoms, to the ...

AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a phase 2 study. The U.K.-based pharma had been evaluating the antisense ...

The plant-focused portfolio diet has been shown to reduce the risks of cardiovascular disease. Here’s how it works. By Caroline Hopkins Legaspi Dr. David Jenkins, a professor of nutritional sciences ...

This is read by an automated voice. Please report any issues or inconsistencies here. AstraZeneca becomes second major pharmaceutical company to agree to lower Medicaid drug prices under Trump ...

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...

President Donald Trump on Friday said that pharmaceutical giant AstraZeneca has struck a deal to sell its drugs to the government’s Medicaid program at a discount, making it the second company to ...